ENDIA研究中1型糖尿病风险儿童外分泌标志物的纵向变化
在ENDIA队列301名有1型糖尿病风险的儿童中,前瞻性检测粪便弹性蛋白酶-1(FE-1)和血清免疫反应性胰蛋白酶(IRT)。采用巢式病例对照设计,比较进展为胰岛自身免疫或1型糖尿病儿童与年龄性别匹配的自身抗体阴性对照儿童的外分泌标志物轨迹。结果显示,后来发生多个胰岛自身抗体或1型糖尿病的儿童在出生后6个月内FE-1较低;IRT在1型糖尿病诊断前12和18个月较低。
要点
- 有1型糖尿病风险的儿童在出生后6个月内FE-1较低与后续发生多个胰岛自身抗体或1型糖尿病相关。
- IRT在1型糖尿病诊断前12和18个月较低,提示外分泌功能变化出现在临床发病前。
- 外分泌生物标志物变化在1型糖尿病自然史早期即可检测到。
核心结论
- 外分泌生物标志物变化在1型糖尿病自然史早期即可检测到,FE-1延迟上升和IRT在胰岛自身抗体血清转换后下降。
研究设计与样本
- 前瞻性队列研究,纳入301名有1型糖尿病风险的儿童,其中216名提供1,679份粪便样本,242名提供1,014份血清样本。
- 采用巢式病例对照设计,比较进展为胰岛自身免疫或1型糖尿病儿童与年龄性别匹配的自身抗体阴性对照儿童。
- 使用调整线性混合模型分析生物标志物轨迹。
主要发现
- 后来发生多个胰岛自身抗体或1型糖尿病的儿童出生时FE-1较低(β系数 -0.61 [95% CI -1.04, -0.17];P = 0.006)。
- 上述儿童3个月时FE-1较低(β系数 -0.39 [95% CI -0.69, -0.09];P = 0.010)。
- 发生1型糖尿病的儿童在诊断前12个月IRT较低(β = -0.30 [95% CI -0.58, -0.02];P = 0.034)。
- 发生1型糖尿病的儿童在诊断前18个月IRT较低(β = -0.40 [95% CI -0.71, -0.10];P = 0.008)。
关键数值与推荐
- FE-1在出生时β系数 -0.61(95% CI -1.04, -0.17),P = 0.006;3个月时β系数 -0.39(95% CI -0.69, -0.09),P = 0.010。
- IRT在1型糖尿病诊断前12个月β = -0.30(95% CI -0.58, -0.02),P = 0.034;诊断前18个月β = -0.40(95% CI -0.71, -0.10),P = 0.008。
临床怎么用
- 外分泌生物标志物(FE-1和IRT)可能有助于在1型糖尿病临床发病前识别外分泌功能变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The exocrine pancreas is increasingly implicated in type 1 diabetes. Noninvasive biomarkers of exocrine function, fecal elastase-1 (FE-1) and serum immunoreactive trypsin (IRT), may provide early insight into disease pathogenesis. We investigated the temporal relationship between exocrine biomarkers and type 1 diabetes development in children. RESEARCH DESIGN AND METHODS: FE-1 and IRT concentrations were measured prospectively in 301 at-risk children followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) cohort from birth. A total of 216 children provided 1,679 stool samples; 242 provided 1,014 serum samples. Biomarker trajectories were compared between children who developed islet autoimmunity or type 1 diabetes and age- and sex-matched control children negative for autoantibodies in a nested case-control design. Adjusted linear mixed models were used. RESULTS: Two biomarker patterns were observed. FE-1 concentrations were lower during the first 6 months of life in children who subsequently developed multiple islet autoantibodies or type 1 diabetes (β-coefficient at birth -0.61 [95% CI -1.04, -0.17]; P = 0.006; β-coefficient at 3 months -0.39 [95% CI -0.69, -0.09]; P = 0.010); IRT concentrations were lower in children who developed type 1 diabetes 12 months (β = -0.30 [95% CI -0.58, -0.02]; P = 0.034) and 18 months (β = -0.40 [95% CI -0.71, -0.10]; P = 0.008) before type 1 diabetes diagnosis. CONCLUSIONS: Changes in exocrine biomarkers were detectable early in the natural history of type 1 diabetes, with a delayed rise of FE-1 in infants who later progressed to multiple islet autoantibodies or type 1 diabetes and a decrease in IRT following islet autoantibody seroconversion.
引用
- Hall M, Penno MAS, Spelman T, et al. Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA Study. Diabetes Care. 2026. PMID: 42969688. doi:10.2337/dc26-1627
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。